• 1. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952

Professional Introduction to 2-Acetamido-5-nitropyridine (CAS No. 5093-64-1)

2-Acetamido-5-nitropyridine, identified by its Chemical Abstracts Service (CAS) number 5093-64-1, is a significant compound in the field of chemical and pharmaceutical research. This heterocyclic organic molecule, featuring a pyridine core with nitro and acetamido functional groups, has garnered considerable attention due to its versatile applications in medicinal chemistry and drug development. The structural attributes of 2-Acetamido-5-nitropyridine make it a valuable intermediate in synthesizing various bioactive molecules, particularly those targeting neurological and inflammatory disorders.

The compound's molecular structure consists of a pyridine ring substituted at the 2-position with an acetamido group (-NHCOCH?) and at the 5-position with a nitro group (-NO?). This arrangement imparts unique electronic and steric properties, enabling its utility in designing molecules with specific biological activities. The presence of both electron-withdrawing and electron-donating groups facilitates diverse chemical transformations, making it a preferred scaffold for medicinal chemists.

In recent years, 2-Acetamido-5-nitropyridine has been extensively studied for its potential in developing novel therapeutic agents. One of the most promising areas of research involves its application in the treatment of neurodegenerative diseases. Studies have demonstrated that derivatives of this compound can interact with specific neurotransmitter receptors, potentially modulating pathways associated with conditions such as Alzheimer's disease and Parkinson's disease. The nitro group, in particular, has been shown to enhance blood-brain barrier penetration, improving the bioavailability of drug candidates derived from 2-Acetamido-5-nitropyridine.

Furthermore, the acetamido moiety provides a site for further functionalization, allowing chemists to introduce additional pharmacophores that enhance binding affinity and selectivity. This flexibility has led to the synthesis of several analogs that exhibit potent anti-inflammatory properties. Researchers have observed that certain derivatives can inhibit key enzymes involved in the inflammatory response, such as cyclooxygenase (COX) and lipoxygenase (LOX), without causing significant side effects. These findings highlight the compound's potential as a lead molecule for developing next-generation anti-inflammatory drugs.

The pharmaceutical industry has also explored 2-Acetamido-5-nitropyridine as a precursor for antiviral agents. The unique electronic environment created by the nitro and acetamido groups allows for interactions with viral proteases and polymerases, disrupting viral replication cycles. Preliminary studies have shown that certain derivatives can inhibit the replication of RNA viruses by interfering with critical enzymatic steps. While further research is needed to optimize efficacy and safety profiles, these results are encouraging for future antiviral drug development.

From a synthetic chemistry perspective, 2-Acetamido-5-nitropyridine serves as an excellent building block for constructing more complex heterocyclic frameworks. Its reactivity allows for various transformations, including reduction of the nitro group to an amine, nucleophilic substitution at the pyridine ring, and coupling reactions to introduce additional functional groups. These synthetic possibilities have enabled the rapid discovery of novel compounds with tailored biological activities.

The growing interest in 2-Acetamido-5-nitropyridine has spurred advancements in synthetic methodologies aimed at improving its production efficiency and scalability. Modern techniques such as flow chemistry and catalytic processes have been employed to enhance yield and purity while minimizing environmental impact. These innovations not only facilitate academic research but also support industrial applications by providing high-quality starting materials for drug development programs.

In conclusion, 2-Acetamido-5-nitropyridine (CAS No. 5093-64-1) is a multifaceted compound with significant potential in pharmaceutical research. Its unique structural features enable diverse applications across multiple therapeutic areas, including neurodegenerative diseases, inflammation, and antiviral treatments. Ongoing studies continue to uncover new possibilities for utilizing this compound as a lead molecule or intermediate in drug discovery efforts. As synthetic methodologies evolve and our understanding of its biological interactions deepens, 2-Acetamido-5-nitropyridine is poised to remain a cornerstone in medicinal chemistry research.

• 1075-62-3(2-Acetamido-6-aminopyridine)
• 5327-32-2(2-Acetylamino-4-methylpyridine)
• 4093-89-4(N-methyl-5-nitropyridin-2-amine)
• 4214-76-0(5-nitropyridin-2-amine)
• 4487-50-7(4-Nitropyridin-2-amine)
• 5231-96-9(2-Acetamidopyridine)
• 6760-14-1(2-amino-5-nitropyridine-3-carboxylic acid)
• 4214-75-9(2-Amino-3-nitropyridine)
• 3537-14-2(5-Nitropyridine-2,3-diamine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)